Ehsan Dadgostar

1.3k total citations
47 papers, 908 citations indexed

About

Ehsan Dadgostar is a scholar working on Molecular Biology, Neurology and Epidemiology. According to data from OpenAlex, Ehsan Dadgostar has authored 47 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Neurology and 9 papers in Epidemiology. Recurrent topics in Ehsan Dadgostar's work include Cancer-related molecular mechanisms research (6 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Ehsan Dadgostar is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Ehsan Dadgostar collaborates with scholars based in Iran, United States and Canada. Ehsan Dadgostar's co-authors include Omid Reza Tamtaji, Zatollah Asemi, Ebrahim Kouchaki, Kamran Bagheri Lankarani, Reza Tabrizi, Maryam Akbari, Reza Daneshvar Kakhaki, Hossein Akbari, Hassan Nikoueinejad and Hamed Mirzaei and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Critical Reviews in Food Science and Nutrition.

In The Last Decade

Ehsan Dadgostar

45 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ehsan Dadgostar Iran 17 251 193 166 115 100 47 908
Can Erzık Türkiye 17 212 0.8× 167 0.9× 78 0.5× 79 0.7× 88 0.9× 48 825
Andréa Rodrigues Vasconcelos Brazil 15 338 1.3× 280 1.5× 52 0.3× 57 0.5× 102 1.0× 21 971
Fangfang Bi China 16 500 2.0× 137 0.7× 70 0.4× 112 1.0× 30 0.3× 33 992
Sergio Rius‐Pérez Spain 16 554 2.2× 315 1.6× 49 0.3× 188 1.6× 131 1.3× 24 1.4k
Yue Lu China 19 590 2.4× 144 0.7× 442 2.7× 132 1.1× 50 0.5× 48 1.4k
Junzhen Wu China 16 368 1.5× 284 1.5× 38 0.2× 137 1.2× 53 0.5× 41 1.3k
Mina Abdolahi Iran 18 282 1.1× 281 1.5× 52 0.3× 59 0.5× 108 1.1× 44 934
Shijin Xia China 24 875 3.5× 453 2.3× 73 0.4× 159 1.4× 108 1.1× 47 2.0k
Mohammad Khalili Iran 18 387 1.5× 196 1.0× 113 0.7× 64 0.6× 166 1.7× 40 989
Liping Yang China 18 420 1.7× 213 1.1× 33 0.2× 186 1.6× 59 0.6× 58 1.3k

Countries citing papers authored by Ehsan Dadgostar

Since Specialization
Citations

This map shows the geographic impact of Ehsan Dadgostar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehsan Dadgostar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehsan Dadgostar more than expected).

Fields of papers citing papers by Ehsan Dadgostar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ehsan Dadgostar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehsan Dadgostar. The network helps show where Ehsan Dadgostar may publish in the future.

Co-authorship network of co-authors of Ehsan Dadgostar

This figure shows the co-authorship network connecting the top 25 collaborators of Ehsan Dadgostar. A scholar is included among the top collaborators of Ehsan Dadgostar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ehsan Dadgostar. Ehsan Dadgostar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mohammadpour, Mahdi, et al.. (2025). Non-coding RNA biomarkers in Alzheimer’s disease. Clinica Chimica Acta. 576. 120427–120427. 1 indexed citations
2.
Dadgostar, Ehsan, et al.. (2025). Long non-coding RNAs in bipolar disorder. Clinica Chimica Acta. 572. 120265–120265. 1 indexed citations
3.
Alinaghipour, Azam, Ehsan Dadgostar, Michael Aschner, et al.. (2024). The Potential of Targeting Autophagy-Related Non-coding RNAs in the Treatment of Alzheimer’s and Parkinson’s Diseases. Cellular and Molecular Neurobiology. 44(1). 28–28. 9 indexed citations
4.
Elyasi, Forouzan, et al.. (2024). Opium and Tobacco Use, and Outcome in COVID-19 Infected Patients: A Cross-Sectional Study. international journal high risk behaviors & addiction. 13(2).
5.
Asadi, Amir, et al.. (2024). Electrochemical biosensors for depression: Diagnosis and therapeutic monitoring. Clinica Chimica Acta. 567. 120091–120091. 13 indexed citations
6.
Dadgostar, Ehsan, et al.. (2024). Nutritional Strategies in Major Depression Disorder: From Ketogenic Diet to Modulation of the Microbiota-Gut-Brain Axis. Molecular Neurobiology. 62(3). 2973–2994. 3 indexed citations
7.
Dadgostar, Ehsan, Hamed Jafarpour, Michael Aschner, et al.. (2024). Potential of Edaravone Dexborneol in the treatment of cerebral ischemia: focus on cell death-related signaling pathways. Molecular Biology Reports. 51(1). 1007–1007. 1 indexed citations
8.
Alinaghipour, Azam, Ehsan Dadgostar, Michael Aschner, et al.. (2023). Non-Coding RNAs and Neurodegenerative Diseases: Information of their Roles in Apoptosis. Molecular Neurobiology. 61(7). 4508–4537. 4 indexed citations
9.
Dadgostar, Ehsan, et al.. (2023). Non-coding RNAs and Aquaporin 4: Their Role in the Pathogenesis of Neurological Disorders. Neurochemical Research. 49(3). 583–596. 2 indexed citations
10.
Taghizadieh, Mohammad, et al.. (2022). Correlations between single nucleotide polymorphisms in obsessive-compulsive disorder with the clinical features or response to therapy. Journal of Psychiatric Research. 157. 223–238. 2 indexed citations
11.
Dadgostar, Ehsan, et al.. (2022). Can Berberine Serve as a New Therapy for Parkinson’s Disease?. Neurotoxicity Research. 40(4). 1096–1102. 7 indexed citations
12.
Dadgostar, Ehsan, et al.. (2022). Aquaporin 4 in Traumatic Brain Injury: From Molecular Pathways to Therapeutic Target. Neurochemical Research. 47(4). 860–871. 24 indexed citations
13.
Mirzaei, Hamed, Ebrahim Kouchaki, Erfaneh Barati, et al.. (2021). Probiotics and the Treatment of Parkinson's Disease: An Update. Cellular and Molecular Neurobiology. 42(8). 2449–2457. 35 indexed citations
14.
Tamtaji, Omid Reza, Alireza Milajerdi, Željko Reiner, et al.. (2020). A systematic review and meta-analysis: The effects of probiotic supplementation on metabolic profile in patients with neurological disorders. Complementary Therapies in Medicine. 53. 102507–102507. 20 indexed citations
15.
16.
Shamshirian, Amir, Amirhossein Hessami, Keyvan Heydari, et al.. (2020). The Role of Hydroxychloroquine in COVID-19 Treatment: A Systematic Review and Meta-Analysis. Annals of the Academy of Medicine Singapore. 9 indexed citations
17.
Ghaffarpasand, Fariborz, et al.. (2019). Intravenous Acetaminophen (Paracetamol) for Postcraniotomy Pain: Systematic Review and Meta-Analysis of Randomized Controlled Trials. World Neurosurgery. 134. 569–576. 13 indexed citations
18.
Akbari, Hossein, et al.. (2019). Comparison of psychiatric screening Instruments: GHQ-28, BSI and MMPI. SHILAP Revista de lepidopterología. 8(4). 1337–1337. 3 indexed citations
19.
Kouchaki, Ebrahim, Reza Daneshvar Kakhaki, Omid Reza Tamtaji, et al.. (2018). Increased serum levels of TNF-α and decreased serum levels of IL-27 in patients with Parkinson disease and their correlation with disease severity. Clinical Neurology and Neurosurgery. 166. 76–79. 57 indexed citations
20.
Taghizadeh, Mohsen, Omid Reza Tamtaji, Ehsan Dadgostar, et al.. (2017). The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson's disease: A randomized, double-blind, placebo-controlled trial. Neurochemistry International. 108. 183–189. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Can Erzık Breakdown of academic impact, for papers by Andréa Rodrigues Vasconcelos Breakdown of academic impact, for papers by Fangfang Bi Breakdown of academic impact, for papers by Sergio Rius‐Pérez Breakdown of academic impact, for papers by Yue Lu Breakdown of academic impact, for papers by Junzhen Wu Breakdown of academic impact, for papers by Mina Abdolahi Breakdown of academic impact, for papers by Shijin Xia Breakdown of academic impact, for papers by Mohammad Khalili Breakdown of academic impact, for papers by Liping Yang
Rankless by CCL
2026